There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - Senate

Short Titles as Introduced

Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to amend the Toxic Substances Control Act, and for other purposes.

Actions Overview (1)

03/12/2015Introduced in Senate

All Actions (1)

03/12/2015Read twice and referred to the Committee on Environment and Public Works.
Action By: Senate

Cosponsors (5)

* = Original cosponsor
CosponsorDate Cosponsored
Sen. Markey, Edward J. [D-MA]* 03/12/2015
Sen. Sanders, Bernard [I-VT]* 03/12/2015
Sen. Gillibrand, Kirsten E. [D-NY] 03/23/2015
Sen. Blumenthal, Richard [D-CT] 03/23/2015
Sen. Mikulski, Barbara A. [D-MD] 04/15/2015

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
Senate Environment and Public Works03/12/2015 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.

Latest Summary (1)

There is one summary for S.725. View summaries

Shown Here:
Introduced in Senate (03/12/2015)

Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act

This bill amends the Toxic Substances Control Act (TSCA) to revise the regulation of chemicals.

A safety standard is established to ensure with reasonable certainty that no harm to human health or the environment will result from exposure to a chemical under the intended or reasonable foreseeable conditions of use. The standard includes the protection of potentially exposed or susceptible populations. The standard does not take cost or other non-risk factors into consideration.

The bill expands the Environmental Protection Agency's (EPA) authority to require the development of new information about a chemical.

By specified deadlines, the EPA must designate a certain number of existing chemicals as high or low priority for safety assessments and determinations and conduct risk-based safety assessments and determinations for high priority chemicals. Low-priority designations are subject to judicial review.

The EPA must prohibit or restrict the manufacture, processing, use, distribution, or disposal of a new chemical, or a significant new use of an existing chemical, if the chemical will not likely meet the safety standard, or additional information is necessary to make a safety determination.

If a chemical does not meet the safety standard, the EPA must impose restrictions to assure that it meets the standard, or ban or phase out the chemical when the safety standard cannot be met with the application of those restrictions.

The EPA may declare a proposed rule effective upon publication to protect the public interest when certain activities involving chemicals are likely to result in a significant risk of serious or widespread injury to health or the environment.

The EPA must: (1) list all forms of asbestos as high-priority chemicals; and (2) expedite identification, assessment, and action on persistent, bio-accumulative, and toxic chemicals.

Confidential business information claims to protect information related to chemicals must be substantiated by manufacturers or processors and reviewed by the EPA. The bill sets forth the types of information that are protected from disclosure and the duration of such protection.

The EPA must require manufacturers of chemical substances to pay fees to defray the cost of administering this bill.

The EPA must operate Regional Disease Cluster Information and Response Centers and Regional Disease Cluster Information and Response Teams and may award grants for technical assistance for the investigation and mitigation of a community-based disease cluster. A "disease cluster" means the occurrence of a greater-than-expected number of cases of a particular disease within a group of individuals, a geographic area, or a period of time.